Literature DB >> 19636710

In situ forming formulation: development, evaluation, and optimization using 3(3) factorial design.

Ramesh C Nagarwal1, A Srinatha, Jayanta K Pandit.   

Abstract

The present investigation concerns with the development and optimization of an in situ forming formulation using 3(3) full factorial design experimentation. Metformin, an antidiabetic drug with upper part of gastrointestinal tract as absorption window was used as a model drug. The formulations were designed with an objective to retain in stomach for an extended time period. The effect of three independent factors--concentrations of sodium alginate (X(1)), gellan gum (X(2)), and metformin (X(3)) on in vitro drug release were used to characterize and optimize the formulation. Five dependent variables-release exponent (Y(1)), dissolution efficiency (Y(2)), drug release at 30 min (Y(3)), 210 min (Y(4)), and 480 min (Y(5)) were considered as optimization factors. The data were statistically analyzed using ANOVA, and a p < 0.05 was considered statistically significant. Three dimensional surface response plots were drawn to evaluate the interaction of independent variables on the chosen dependent variables. Of the prepared 27 formulations, the responses exhibited by batch F17 containing medium level sodium alginate (X(1)), low level gellan (X(2)), and medium level metformin (X(3)) were similar to the predicted responses.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19636710      PMCID: PMC2802170          DOI: 10.1208/s12249-009-9285-3

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  12 in total

1.  Robustness testing, using experimental design, of a flow-through dissolution method for a product where the actives have markedly differing solubility properties.

Authors:  M S Bloomfield; W C Butler
Journal:  Int J Pharm       Date:  2000-09-25       Impact factor: 5.875

2.  Oral sustained delivery of paracetamol from in situ-gelling gellan and sodium alginate formulations.

Authors:  Wataru Kubo; Shozo Miyazaki; David Attwood
Journal:  Int J Pharm       Date:  2003-06-04       Impact factor: 5.875

3.  MECHANISM OF SUSTAINED-ACTION MEDICATION. THEORETICAL ANALYSIS OF RATE OF RELEASE OF SOLID DRUGS DISPERSED IN SOLID MATRICES.

Authors:  T HIGUCHI
Journal:  J Pharm Sci       Date:  1963-12       Impact factor: 3.534

4.  Development of polysaccharide gel-coated pellets for oral administration. 2. Calcium alginate.

Authors:  Pornsak Sriamornsak; Ross A Kennedy
Journal:  Eur J Pharm Sci       Date:  2006-06-27       Impact factor: 4.384

5.  Food intake and dosage level, but not tablet vs solution dosage form, affect the absorption of metformin HCl in man.

Authors:  N C Sambol; L G Brookes; J Chiang; A M Goodman; E T Lin; C Y Liu; L Z Benet
Journal:  Br J Clin Pharmacol       Date:  1996-10       Impact factor: 4.335

Review 6.  Clinical pharmacokinetics of metformin.

Authors:  A J Scheen
Journal:  Clin Pharmacokinet       Date:  1996-05       Impact factor: 6.447

7.  Comparison of in situ gelling formulations for the oral delivery of cimetidine.

Authors:  S Miyazaki; N Kawasaki; W Kubo; K Endo; D Attwood
Journal:  Int J Pharm       Date:  2001-06-04       Impact factor: 5.875

8.  Optimisation of floating matrix tablets and evaluation of their gastric residence time.

Authors:  S Baumgartner; J Kristl; F Vrecer; P Vodopivec; B Zorko
Journal:  Int J Pharm       Date:  2000-02-15       Impact factor: 5.875

9.  Application of experimental design methodology in development and optimization of drug release method.

Authors:  M Kincl; S Turk; F Vrecer
Journal:  Int J Pharm       Date:  2005-01-12       Impact factor: 5.875

10.  Preparation of alginate beads for floating drug delivery system: effects of CO(2) gas-forming agents.

Authors:  B Y Choi; H J Park; S J Hwang; J B Park
Journal:  Int J Pharm       Date:  2002-06-04       Impact factor: 5.875

View more
  8 in total

1.  QbD-Enabled Development of Novel Stimuli-Responsive Gastroretentive Systems of Acyclovir for Improved Patient Compliance and Biopharmaceutical Performance.

Authors:  Bhupinder Singh; Anterpreet Kaur; Shashi Dhiman; Babita Garg; Rajneet Kaur Khurana; Sarwar Beg
Journal:  AAPS PharmSciTech       Date:  2015-08-04       Impact factor: 3.246

2.  Formulation and evaluation of periodontal in situ gel.

Authors:  Kevin Garala; Parth Joshi; Malay Shah; A Ramkishan; Jaydeep Patel
Journal:  Int J Pharm Investig       Date:  2013-01

3.  Introduction of a mathematical model for optimizing the drug release in the patient's body.

Authors:  Mohammad Reza Nabatchian; Hamid Shahriari; Mona Shahriari
Journal:  Daru       Date:  2014-01-03       Impact factor: 3.117

4.  Development of topical ophthalmic In Situ gel-forming estradiol delivery system intended for the prevention of age-related cataracts.

Authors:  Udaya K Kotreka; Vicki L Davis; Moji C Adeyeye
Journal:  PLoS One       Date:  2017-02-21       Impact factor: 3.240

5.  Gastroretentive raft liquid delivery system as a new approach to release extension for carrier-mediated drug.

Authors:  Samar M Abouelatta; Ahmed A Aboelwafa; Omaima N El-Gazayerly
Journal:  Drug Deliv       Date:  2018-11       Impact factor: 6.419

6.  Gelucire based in situ gelling emulsions: a potential carrier for sustained stomach specific delivery of gastric irritant drugs.

Authors:  Ashwin Saxena; Arun K Mishra; Navneet Verma; Shiv S Bhattacharya; Amitava Ghosh; Anurag Verma; Jayanta K Pandit
Journal:  Biomed Res Int       Date:  2013-11-10       Impact factor: 3.411

7.  Xyloglucan Based In Situ Gel of Lidocaine HCl for the Treatment of Periodontosis.

Authors:  Ashlesha P Pandit; Vaibhav V Pol; Vinit S Kulkarni
Journal:  J Pharm (Cairo)       Date:  2016-01-28

8.  Full factorial design for optimization, development and validation of HPLC method to determine valsartan in nanoparticles.

Authors:  Lalit Kumar; M Sreenivasa Reddy; Renuka S Managuli; Girish Pai K
Journal:  Saudi Pharm J       Date:  2015-03-03       Impact factor: 4.330

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.